Induction of tumor necrosis factor α production by adhered human monocytes: A key role for Fcγ receptor type IIIA in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 3, 2000, Pages 608-616

  Abrahams, Vikki M ^a   Cambridge, Geraldine ^a   Lydyard, Peter M ^a   Edwards, Jonathan C W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FC RECEPTOR; INTERLEUKIN 1ALPHA; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ADHESION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CELL ADHESION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MONOCYTES; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034129910     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G     Document Type: Article

References (33)

1. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
2. McInnes IB, Liew FY. Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today 1998;19:75-9.
3. Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, 't Hart BA, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998;41:1481-8.
4. Kurosaka M, Ziff M. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med 1983;158:1191-210.
5. Maini RN, Zvaifler N. Rheumatoid arthritis. In: Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. London: Mosby; 1998. p. 5.1.1-5.15.10.
6. Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterisation and relationship to lowered complement levels. Clin Exp Immunol 1970;6:689-706.
7. Mannik M, Nardella FA. IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis 1995;11:551-72.
8. Walport MJ, Davies KA, Morley BJ, Botto M. Complement deficiency and autoimmunity. Ann N Y Acad Sci 1997;815:267-81.
9. Pope RM, Teller DC, Mannik M. The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc Natl Acad Sci U S A 1974;71:517-21.
10. Nardella FA, Teller DC, Mannik M. Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J Exp Med 1981;154:112-25.
11. Brown PB, Nardella FA, Mannik M. Human complement activation by self-associated IgG rheumatoid factors. Arthritis Rheum 1982;25:1101-7.
12. Edwards JCW, Cambridge G, Abrahams VM. Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 1999;97:188-96.
13. Unkeless JC. Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest 1989;83:355-61.
14. Fanger MW, Shen L, Graziano RF, Guyre PM. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 1989; 10:92-9.
15. Van de Winkel JGJ. Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993;14:215-21.
16. Bhatia A, Blades S, Cambridge G, Edwards JCW. Differential distribution of FcγRIIIA in normal human tissues and colocalisation with DAF and fibrillin-1. Immunology 1998;94:56-63.
17. Klaassen RJL, Goldschmeding R, Tetteroo PAT, von dem Borne AEGK. The Fc valency of an immune complex is the decisive factor for binding to low-affinity Fey receptors. Eur J Immunol 1988;18:1373-7.
18. Edwards JCW, Cambridge G. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br J Rheumatol 1998;37:126-30.
19. Debets JMH, van de Winkel JGJ, Ceuppens JL, Dieteren IEM, Buurman WA. Cross-linking of both FcγRI and FcγRII induces secretion of tumour necrosis factor by human monocytes, requiring high affinity Fc-FcγR interaction: functional activation of FcγRII by treatment with proteases or neuraminidase. J Immunol 1990;144:1304-10.
20. Agegon I, Cuturi MC, Trinchieri G, Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988;167:452-72.
21. Hendrich C, Kuipers JG, Kolanus W, Hammer M, Schmidt RE. Activation of CD16-effector cells by rheumatoid factor complex: role of natural killer cells in rheumatoid arthritis. Arthritis Rheum 1991;34:423-31.
22. Fleit HB, Wright SD, Unkeless JC. Human neutrophil Fcγ receptor distribution and structure. Proc Natl Acad Sci U S A 1982;79: 3275-9.
23. Looney RJ, Ryan DH, Takahashi K, Fleit HB, Cohen HJ, Abraham GN, et al. Identification of a second class of IgG Fc receptors on human neutrophils: a 40 kilodalton molecule also found on cosinophils. J Exp Med 1986;163:826-36.
24. Dougherty GJ, Selendran Y, Murdoch S, Palmer DG, Hogg N. The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur J Immunol 1987;17:1453-9.
25. Brennan FM, Chantry D, Jackson A, Maini RN, Fcldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin 1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
26. Kipps TJ, Parham P. Punt J, Herzenberg LA. Importance of immunoglobulin isotypc in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 1985;161:1-17.
27. Kocher M, Edberg JC, Fleit HB, Kimberly RP. Antineutrophil cytoplasmic antibodies preferentially engage Fc gamma RIIIb on human neutrophils. J Immunol 1998;161:6909-14.
28. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G. Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982;2:49-53.
29. Saklatavala J. TNFα stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
30. Bresnihan B, Alvaro-Garcia JM, Cobby M, Doherty M, Domljan Z, Emery P, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998;41:2196-204.
31. Leeuwenberg JF, Dentener MA, Buurman WA. Lipopolysaccharide (LPS)-mediated soluble TNF receptor release and TNF receptor expression by monocytes: role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein. J Immunol 1994;152:5070-6.
32. Trezzini C, Jungi TW, Spycher MO, Maly FE, Rao P. Human monocytes CD36 and CD16 are signalling molecules: evidence from studies using antibody-induced chemiluminescence as a tool, to probe signal transduction. Immunology 1990;71:29-37.
33. Kunkel HG, Muleer-Eberhand HJ, Fendenberg H, Tomasi TB. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest 1960;40:117-29.